Life Sciences Future
Life Sciences Future, the largest annual gathering of the life sciences community on the east coast, is the conference for all stakeholders of the life sciences ecosystem – biopharma, med tech, academic research, hospitality, legal, financial, real estate communities and more. Conference features include partnering, plenary sessions of broad interest, and focused sessions on timely topics and speakers.
This conference will be the ultimate partnering event on the east coast – with opportunities for one-on-one partnering with the biggest names in the industry.
CONFERENCE FEATURES
Partnering
Access one-on-one partnering with hundreds of the biggest names in the industry.
Panel Discussions
Hear from experts from the life sciences community about the hottest topics in the industry.
Reverse Pitch Presentations
Hear from top life sciences and investment organizations on what they are looking for to fill their portfolio.
Exhibitors
Organizations will showcase their company’s services and network with other attendees.
Poster Presentations
Attendees from academic research institutions and spin-outs will present their cutting-edge science to a panel of reviewers.
Company Presentations
Organizations will present their pitch deck for feedback and partnership opportunities.
SPEAKERS
SCOTT HAMILTON
Olympic Gold Medalist
Cancer Survivor & Activist
The most recognized male figure skating star in the world, Scott Hamilton has won 70 titles, awards and honors including an Emmy Award nomination, induction into the United States Olympic Hall of Fame and a privileged member of the World Figure Skating Hall of Fame.
After losing his mother to cancer, then becoming a survivor himself, Scott turned activist, launching the Scott Hamilton CARES Foundation (Cancer Alliance for Research, Education and Survivorship). He founded several education and survivorship programs including Chemocare.com and the fourth Angel Mentoring Program.
JIM WILSON, MD, PhD
Professor, Medicine and Pediatrics
Director, Gene Therapy Program
James M. Wilson, MD, PhD, is a Professor in the Perelman School of Medicine at the University of Pennsylvania where he has led an effort to develop the field of gene therapy. His research career spanning over 40 years has focused on rare diseases and ways to treat them by gene therapy.
The Wilson lab identified a new type of vector based on novel isolates of adeno-associated viruses which have become best in class for gene therapy. More recently Dr. Wilson’s laboratory has focused on improved vectors for gene therapy and clinical applications of genome editing and mRNA therapy.
Krish Krishnan
Chairman & CEO
Krystal Biotech
Krish Krishnan is the Chairman and CEO of Krystal Biotech, a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases. In May 2023, the FDA approved VYJUVEK for the treatment of patients six months of age or older with dystrophic epidermolysis bullosa (DEB).
Throughout his career, Krish was specifically involved in two successful IPOs, the approval of the blockbuster drug Vyvanse (for ADHD in 2007) and the sale of New River Pharmaceuticals to Shire Pharmaceuticals.
COMPANY REVERSE PITCH PRESENTERS
Conference Co-Chairs:
Tara Muzsi, Vice President, Immunology Sales & Marketing, Gastroenterology, Janssen
John Witkowski, President, DSM Biomedical
Mike Bowman, President & CEO, Valley Forge Tourism & Convention Board
THANK YOU TO OUR SPONSORS
Committees & Chairs:
Academic Outreach – Identify issues and opportunities faced by research institutions, early to mid-stage companies, and business development teams forging early-stage relationships. Suggest speakers that should be considered, either from your own research institutions or individuals you have heard at other conferences.
- Kenny Simansky, Drexel University
- John Swartley, Penn Center for Innovation, University of Pennsylvania
- Erika Swift, Center for Medical Innovation, Penn State College of Medicine
Advocacy – Assist with identifying topics and speakers who would share pertinent information about policy from state and federal government.
- Dom Argento, State Government Affairs & Policy, Merck
- Amy Redl, Federal Government Relations, Sanofi
Company Presentations – Help identify new and emerging companies to present during the Company Presentation portion of LSF. Presenting companies will be selected by a review committee.
- John Pennett, EisnerAmper
- Doreen Trujilo, Saul Ewing
Hospitality, Meetings & Conventions – What effect does the life sciences community have in the hospitality, meetings, and conventions industry? Help identify key topics to cover during the conference that highlight the life sciences community and its intersections with the hospitality industry.
- Bonnie Grant, Convention & Visitors Bureau
- Lisa Karl, Valley Forge Tourism & Convention Board
Program/Agenda – Assist with identifying conference topics and conference speakers. LSPA will facilitate outreach to speakers and will keep the committee updated on the progress.
- Maureen Mulvihill, Actuated Medical
- Neal Walker, Aclaris Therapeutics
Promotional Outreach – Assist with getting the word out! Strategizing ideas on communication tactics that will drive interest in LSF.
- Ed Seiders, 20/20 Visual Media
- Kathena Siegel, DSM Biomedical
Real Estate – It’s the hottest time in life sciences real estate in decades. Tell us why… and help tell the conference why!
- Joe Colletti, JLL
- John Grady, Wexford Science + Technology
Talent – What do leaders need to know to be up-to-date on the newest trends in talent recruitment, development and retention? What about DE&I initiatives and other employee priorities in today’s fast-changing climate.
- Bert Bruce, Pfizer
- Marcia O’Connor, The O’Connor Group